The effect of K-ATP channel blockage during erythropoietin treatment in renal ischemia-reperfusion injury

Journal of Investigative Surgery

Volumn 21, Issue 6, 2008, Pages 340-347

  Yazihan, Nuray ^a,b   Ataoglu, Haluk ^a,c   Kavas, Guzin Ozelci ^a   Akyurek, Nalan ^d   Yener, Burcu ^a   Aydm, Cengiz ^e  

^a ANKARA UNIVERSITY   (Turkey)

^b Pathophysiology Department   (Turkey)

^c Microbiology Department   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

^e Yuksek Ihtisas Heart Education and Research Hospital   (Turkey)

Author keywords

(FeNa); ATP dependent K channels; Caspase 3; Erythropoietin (EPO); Fractional potassium excretion (FeK); Fractional sodium excretion; Glibenclamide; Glomerular filtration rate (GFR); Renal ischemia reperfusion (IR) injury; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATE DEPENDENT POTASSIUM CHANNEL; CASPASE 3; GLIBENCLAMIDE; POTASSIUM; POTASSIUM CHANNEL; RECOMBINANT ERYTHROPOIETIN; SODIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CASP3 PROTEIN, RAT; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REPERFUSION INJURY; SODIUM EXCRETION; ANIMAL; APOPTOSIS; DRUG ANTAGONISM; INJURY; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; APOPTOSIS; CASPASE 3; EPOETIN ALFA; GLOMERULAR FILTRATION RATE; GLYBURIDE; KATP CHANNELS; KIDNEY; MALE; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61749084131     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930802438906     Document Type: Article

References (32)

1. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxiareoxygenation injury. Am J Physiol Cell Physiol. 2002;282:227-241.
2. Bonventre JV. Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation. Contrib Nephrol. 2007;156:39-46.
3. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol. 2003;284:608-627.
4. Gobe G, Willgoss D, Hogg N, et al. Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int. 1999;56:1299-1304.
5. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 2004;11:37-44.
6. Brines M, Cerami A. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int. 2006; 70:246-250.
7. Sun Y, Calvert JW, Zhang JH. Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke.2005;36:1672-1678.
8. Kumral A, Gonenc S, Acikgoz O, et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol Neonate. 2005;87:15-18.
9. Sharples EJ, Yaqoob MM. Erythropoietin in experimental acute renal failure. Nephron Exp Nephrol. 2006;104:83-88.
10. Joyeux-Faure M, Ramond A, Beguin PC, et al. Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart. Fundam Clin Pharmacol. 2006;20:51-56.
11. Shi YP, Rafiee J, Su J, et al. Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. Basic Res Cardiol. 2004;99:173-182.
12. Hanlon PR, Fu P, Wright GL, et al. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J. 2005;19:1323-1325.
13. Imamura R, Moriyama T, Isaka Y, et al. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha. Transplantation. 2007;27;83:1371-1379.
14. Spandou E, Tsouchnikas I, Karkavelas G, et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant. 2006;21:330-336.
15. Yang CW, Li C, Jung JY, et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J. 2003;17:1754-1755.
16. Vesey DA, Cheung C, Pat B, et al. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant. 2004;19:348-355.
17. Rafiee P, Shi Y, Su J, et al. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol. 2005;100:187-197.
18. Chatterjee PK, Cuzzocrea S, Brown PA, et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int. 2000;58:658-673.
19. Halestrap AP, Doran E, Gillespie JP, et al. Mitochondria and cell death. Biochem Soc Trans. 2000;28:170-177.
20. Tang XD, Santarelli LC, Heinemann SH, et al. Metabolic regulation of potassium channels. Annu Rev Physiol. 2004;66:131-159.
21. Sun Z, Zhang X, Ito K, et al. Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide. Am J Physiol Renal Physiol. 2008;294:491-498.
22. + channels in rat hearts. Am J Physiol Heart Circ Physiol. 2006;290:1808-1817.
23. Chrissobolis S, Sobey CG. Inwardly rectifying potassium channels in the regulation of vascular tone. Curr Drug Targets. 2003; 4:281-289.
24. Qiu MR, Campbell TJ, Breit SN. A potassium ion channel is involved in cytokine production by activated human macrophages. Clin Exp Immunol. 2002;130:67-74.
25. Okouchi M, Okayama N, Omi H, et al. The antidiabetic agent, gliclazide, reduces high insulin-enhanced neutrophil-transendothelial migration through direct effects on the endothelium. Diabetes Metab Res Rev. 2004;20:232-238.
26. Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann Transplant. 2004;9:81-83.
27. Pompermayer K, Souza DG, Lara GG, et al. The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats. Kidney Int. 2005;67:1785-1796.
28. Zingman LV, Alekseev AE, Hodgson-Zingman DM, et al. ATP-sensitive potassium channels: metabolic sensing and cardioprotection. J Appl Physiol. 2007;103(5):1888-1893.
29. Takashi E, Wang Y, Ashraf M. Activation of mitochondrial K(ATP) channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res. 1999; 3-17;85(12):1146-1153.
30. Von Lindern M, Parren-Von Amehvort M, Von Dijk T, et al. Protein kinase c controls erythropoietin receptor signaling. J Biol Chem. 2000;275:34719-34727
31. Kanagy NL, Perrine MF, Cheung DK, et al. Erythropoietin administration in vivo increases vascular nitric oxide synthase expression. J Cardiovasc Pharmacol. 2003;42(4):527.
32. Gong H, Wang W, Kwon TH, et al. EPO and alpha-MSH prevent ischemia/reperfusion-induced downregulation of AQPs and sodium transporters in rat kidney. Kidney Int. 2004;66:683-695.